Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 27.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 004420 | J. M. Senard [France] ; S. Rai [France] ; M. Lapeyre-Mestre [France] ; C. Brefel [France] ; O. Rascol [France] ; A. Rascol [France] ; J. L. Montastruc [France] | Prevalence of orthostatic hypotension in Parkinson's disease |
| 004484 | J L Montastruc [France] ; J M Senard ; O. Rascol ; A. Rascol | Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences. |
| 004692 | J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. Rascol | Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? |
| 004900 | O. Rascol [France] ; U. Sabatini ; N. Fabre [France] ; J. M. Senard [France] ; M. Simonetta-Moreau [France] ; J. L. Montrastruc [France] ; M. Clanet [France] ; A. Rascol [France] | Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease |
| 004A02 | O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J M Senard [France] ; J L Montastruc [France] ; P. Celsis [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. |
| 004A44 | J L Montastruc [France] ; O. Rascol [France] ; J M Senard [France] ; A. Rascol [France] | A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. |
| 004A78 | O. Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 004C26 | J. M. Senard [France] ; O. Rascol [France] ; B. Chamontin [France] ; A. Rascol [France] ; J.-L. Montastruc [France] | Enregistrement ambulatoire de la pression artérielle dans l'hypotension orthostatique de la maladie de Parkinson |
| 004C35 | O. J. Rascol [France] ; M. Clanet [France] ; J. M. Senard [France] ; J. L. Montastruc [France] ; A. Rascol [France] | Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy |
| 004C51 | J. M. Senard [France] ; O. Rascol [France] ; A. Rascol ; J. L. Montastruc [France] | Lack of yohimbine effect on ambulatory blood pressure recording : a double-blind cross-over trial in Parkinsonians with orthostatic hypotension |
| 004C52 | O. J. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; J. L. Montastruc [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease : improvement by the dopamine agonist apomorphine |
| 004C61 | J. M. Senard [France] ; O. Rascol [France] ; G. Durrieu [France] ; M. A. Tran [France] ; M. Berlan [France] ; A. Rascol ; J. L. Montastruc | Effects of Yohimbine on plasma catecholamine levels in orthostatic hypotension related to Pakinson disease or multiple system atrophy |
| 004D71 | Robert Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse] | Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease |
| 004E33 | O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J.-L. Montastruc ; J.-P. Marc-Vergnes ; A. Rascol | Supplementary and primary sensory motor area activity in Parkinson's disease : regional cerebral blood flow changes during finger movements and effects of apomorphine |
| 004E55 | G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc | Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. |
| 004F52 | A. Agniel [France] ; P. Celsis [France] ; G. Viallard [France] ; J L Montastruc [France] ; O. Rascol [France] ; J F Demonet [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. |
| 004F89 | J. L. Montrastuc [France] ; O. Rascol ; J. M. Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol | Sublingual apomorphine in Parkinson's disease : a clinical and pharmacokinetic study |
| 004F90 | U. Sabatini [France] ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J. P. Marc-Vergnes ; J. L. Montastruc | Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms |
| 004F91 | O. Rascol [France] ; U. Sabatini ; SIMONETTA-MOREAU ; J. L. Montastruc ; A. Rascol ; M. Clanet | Square wave jerks in Parkinsonian syndromes |
| 005011 | G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L Montastruc | Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243). |
| 005012 | G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. Montastruc | Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment. |
| 005104 | J. M. Senard [France] ; P. Valet [France] ; G. Durrieu [France] ; M. Berlan [France] ; M. A. Tran [France] ; J. L. Montastruc [France] ; A. Rascol [France] ; P. Montastruc [France] | Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension |
| 005132 | G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J.-L. Montastruc ; P. Montastruc | β-Adrenergic sensitivity in Parkinson's disease : effect of levodopa treatment |
| 005156 | M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L Montastruc | Alpha 2-adrenergic sensitivity in Parkinson's disease. |
| 005219 | J L Montastruc [France] ; O. Rascol [France] ; A. Rascol [France] | A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. |
| 005380 | M. B. Delisle [France] ; P. Gorce [France] ; E. Hirsch [France] ; J. J. Hauw [France] ; A. Rascol [France] ; H. Bouissou [France] | Motor neuron disease, parkinsonism and dementia |
| 005382 | J. L. Montastruc [France] ; J. L. Celsis [France] ; A. Agniel [France] ; J. F. Demonet [France] ; B. Doyon [France] ; M. Puel [France] ; J. P. Marc-Vergnes [France] ; A. Rascol [France] | Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease |
| This area was generated with Dilib version V0.6.29. |  |